fda 503a bulks list bpc 157 category 2 bpc-157 regulation fda bpc-157 bulk drug substances compounding When will the FDA reclassify BPC-157 to Category 1 FDA's Overreach on Compounded Peptides
FDA's Overreach on Compounded Peptides FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of BREAKING: The FDA just reversed theIR 2023 peptide ban. 12 peptides were just pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu (injectable) FDA considers adding a dozen peptides to its bulk drug compounding list RAPS NBC News The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger looking skin, Instagram BPC 157 and KPV just received favorable PCAC votes for the 503A Bulk Drug Substances List 2 of 7 peptides now recommended Today on July 23, 2026, the FDA's Pharmacy
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



